A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease.

Journal: PLOS Genetics

Published: 2020-04-13

DOI: 10.1371/journal.pgen.1008629

Affiliations: 30

Authors: 41

Go to article
Institutions Share
Program in Medical and Population Genetics, Broad Institute, United States of America (USA) 0.20
Perelman School of Medicine, Penn, United States of America (USA) 0.17
Institute for Molecular Medicine Finland (FIMM), Finland 0.09
Harvard Department of Medicine, United States of America (USA) 0.05
NIHR Leicester Cardiovascular Biomedical Research Unit (LCBRU), United Kingdom (UK) 0.05
Department of Biomedical Informatics (DBMI), VU, United States of America (USA) 0.05
Department of Medicine, VU, United States of America (USA) 0.05
Center for Genomic Medicine (CGM), MGH, United States of America (USA) 0.04
VA Palo Alto Healthcare System (VAPAHCS), United States of America (USA) 0.02
Department of Physiology and Biophysics, Ole Miss, United States of America (USA) 0.02
DZHK Partner Site Munich, Germany 0.02
University of Ottawa Heart Institute (UOHI), uOttawa, Canada 0.02
The Zena and Michael A. Wiener Cardiovascular Institute, ISMMS, United States of America (USA) 0.02
Human Genetics Center (HGC), UTHealth, United States of America (USA) 0.02
DZHK Partner Site Hamburg/Kiel/Lübeck, Germany 0.01
Institute for Cardiogenetics, University of Lübeck, Germany 0.01
Oxford Radcliffe Department of Medicine (RDM), United Kingdom (UK) 0.01
Oxford Wellcome Trust Centre for Human Genetics, United Kingdom (UK) 0.01
Department of Biostatistics, Epidemiology and Informatics (DBEI), Penn, United States of America (USA) 0.01
Associazione per lo Studio della Trombosi in Cardiologia, Italy 0.01
Azienda Ospedaliero, UNIPR, Italy 0.01
Center for Non-Communicable Diseases (CNCD), Pakistan 0.01
Cardiology Division, MGH, United States of America (USA) 0.01
Facultat de Medicina, UVic-UCC, Spain 0.01
NIHR Blood and Transplant Research Unit in Donor Health and Genomics, United Kingdom (UK) 0.01
Wellcome Sanger Institute, United Kingdom (UK) 0.01
Department of Public Health and Primary Care (DPHPC), University of Cambridge, United Kingdom (UK) 0.01
Biomedical Research Networking Center on Cardiovascular Diseases (CIBERCV), Spain 0.01
Cardiovascular Epidemiology and Genetics Research Group, IMIM, Spain 0.01
Verve Therapeutics, Inc., United States of America (USA) 0.01

Return